Oropharyngeal Cancers Withdrawn Phase Trials for Dexlansoprazole (DB05351)

Also known as: Oropharyngeal Cancer / Cancer of Oropharnyx

IndicationStatusPhase
DBCOND0042409 (Oropharyngeal Cancers)WithdrawnNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00928161Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation TherapyTreatment